Subscribe to Newsletter

Companion diagnostics

Diagnostics Companion diagnostics

Precision Pathways

| Luca Quagliata | 4 min read

Towards a world where NGS-based companion diagnostics are available, in house, for every new cancer therapy and every patient

Diagnostics Companion diagnostics

The Story is Still Being Written

| Sponsored by Thermo Fisher Scientific | 5 min read

The ever-developing tale of companion diagnostic tests in precision oncology

Inside the Lab Precision medicine

Closer Coordination, Better Outcomes

| Mark Kruzel | 6 min read

Closer pathology-oncology care team coordination is key to leverage the value of precision therapies and improve outcomes

Diagnostics Companion diagnostics

Collaborating Early to Advance Precision Medicine

| Sponsored by Thermo Fisher Scientific | 7 min read

How companion diagnostic tests are helping cancer patients find personalized answers – and treatments – fast

Diagnostics Analytical science

User experience of the Ion Torrent™ Genexus™ Integrated Sequencer

| Sponsored by Thermo Scientific

Users share their experiences with the Ion Torrent™ Genexus™ platform over the two years since the technology was introduced to the lab community

Diagnostics Companion diagnostics

Atezolizumab Assay Angst

| David Rimm

David Rimm continues the conversation about the best assay for atezolizumab after a recent response to his original article

Diagnostics Companion diagnostics

Which Assay for Atezolizumab?

| Emina Torlakovic, Allen M. Gown

Emina Torlakovic and Allen Gown share their disagreements with David Rimm’s comments about an FDA-approved PD-L1 assay for atezolizumab

Diagnostics Companion diagnostics

What Would Your Oncologist Think If…

| Roberto Salgado

Not every assay that trials well is practical for implementation in daily practice. How can we tell which ones are, and whose responsibility is it?

Diagnostics Companion diagnostics

Improving Patient Outcomes

| Eslie Dennis, Eric Walk, Ken Bloom, Mark Kockx

A response to David Rimm’s letter that supports the role of PD-L1 testing in improving outcomes for cancer patients.

Diagnostics Companion diagnostics

Welcome to Our Kitchen

| David L. Rimm

David Rimm challenges the sensitivity and reproducibility of a new assay for PD-L1 detection.


Latest Application Notes

The next generation of advanced staining

| Contributed by Sakura

All Application Notes

Sister Publications

You might be interested in our Sister Publications:

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register